References
- Botticelli L. J., Cox B. M., Goldstein A. Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia. Proceedings of the National Academy of Sciences, USA 1981; 78: 7783–7786
- Chavkin C., James I. F., Goldstein A. Dynorphin is a specific endogenous ligand of the K opioid receptor. Science 1982; 215: 413–415
- Faden A. I., Jacobs T. P. Dynorphin induces partially reversible paraplegia in the rat. Europaen Journal of Pharmacology 1983; 91: 321–324
- Faden A. I., Jacobs T. P. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action. British Journal of Pharmacology 1984; 81: 271–276
- Goldstein A., Tachibana S., Lowney L. I., Hunkapiller M., Hood L. Dynorphin-(1–13), an extraordinarily potent opioid peptide. Proc. Nalt. Acad. Sci. U.S.A. 1979; 76: 6666–6670
- Han J. S., Xie C. W. Dynorphin: potent analgeic effect in spinal cord of the rat. Life Sciences 1982; 31: 1781–1784
- Han J. S., Xie C. W. Dynorphin: potent analgeic effect in spinal cord of the rat. Science Sin (Ser B) 1984; 27: 169–177
- Herman B. M. Intrathecal dynorphin induces antinociception and paralysis. Society of Neuroscience Abst 1982; 8: 91
- Herman B. M., Goldstein A. Antinociception and paralysis induced by intrathecal dynorphin A. Journal of Pharmacology and Experimental Therapeutics 1985; 232: 27–32
- Herman B. H., Leslie F., Goldstein A. Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1–13) and D-Ala2-dynorphin-(1–11) in rats. Life Sciences 1980; 27: 883–892
- Kakidani H., Furutani Y., Takahashi H., Noda M., Morimoto Y., Hiross T., Asai M., Inayama S., Nakanishi S., Numa S. Cloning and sequence analysis of cDNA for porcine α-neo-endorphin/dynorphin precursor. Nature 1982; 298: 245–248
- Long J. B., Rigamonti D. D., Costa B., Rice K. C., Martinez-Arizala A. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the K opioid antagonist nor-binaltorphimine. Brain Research 1989; 497: 155–162
- Mansour A, Khachaturian H., Lewis M. E., Akil H., Watson S. J. Anatomy of CNS opioid receptors. Trends in Neurosciences 1988; 11: 308–314
- Morris B. J., Herz A. Autoradiographic distribution in rat brain of a non-conventional binding site for the opiate [3H]diprenorphine. Brain Research 1986; 384: 362–366
- Morris B. J., Herz A. Distinct distribution of opioid receptor types in rat lumbar spinal cord. Naunyn-Schmiedeberg's Archives of Pharmacology 1987; 336: 240–243
- Piercey M. F., Varner K., Schroeder L. A. Analgesic activity of intraspinally administered dynorphin and ethylketocyclazocine. European Journal of Pharmacology 1982; 80: 283–284
- Przewlocki R., Shearman G. T., Herz A. Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats. Neuropeptides 1983; 3: 233–240
- Rivlin A. S., Tator C. H. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. Journal of Neurosurgery 1977; 47: 577–581
- Spampinato S., Candeletti S. Characterization of dynorphin A-induced antinociception at spinal level. European Journal of Pharmacology 1985; 110: 21–30
- Stevens C. W., Yaksh T. L. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity. Journal of pharmacology and Experimental Therapeurics 1986; 238: 833–828
- Tung A., Yaksh T. L. In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord. Brain Research 1982; 247: 75–43
- Walker J. M., Katz R. J., Akil H. Behavioral effects of dynorphin-(l -13) in the mouse and rat: initial observations. Peptides 1982a; 1: 341–345
- Walker J. M., Moises H. C., Coy D. H., Young E. A., Watson S. J., Akil H. Dynorphin (1–17): lack of analgesia but evience for non-opiate electrophysiological and motor effects. Life Sciences 1982b; 31: 1821–1824
- Yaksh T. L., Rudy T. A. Chronic catheterization of the spinal subarachnoid space. Physiology and Behavior 1976; 17: 1031–1036